.Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01B_Antimalarials.P01BF09_ArtesunateSulfadoxineAndPyrimeth.ArtesunateSulfadoxineAndPyrimeth .Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01B_Antimalarials.P01BF09_ArtesunateSulfadoxineAndPyrimeth.ArtesunateSulfadoxineAndPyrimeth| name: | ArtesunateSulfadoxineAndPyrimethamine |
| ATC code: | P01BF09 | route: | oral |
| n-compartments | 2 |
Artesunate, sulfadoxine and pyrimethamine is a fixed-dose combination antimalarial drug regimen used for the treatment of uncomplicated malaria caused by Plasmodium falciparum. Artesunate is a fast-acting artemisinin derivative, while sulfadoxine and pyrimethamine inhibit folate synthesis in the parasite. Combination therapy helps delay resistance and improve efficacy. Artesunate-sulfadoxine-pyrimethamine is approved and used in some malaria-endemic countries including India and parts of Africa.
Pharmacokinetic parameters estimated for adults, healthy volunteers and malaria patients, as reported in the literature, per component drug (reporting median or typical values where available).